Q: Are you aware of any particular reason for the share price plunge in ISRG? Would you be a buyer around this level ($280)?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
Illumina Inc. (ILMN $141.07)
-
Intuitive Surgical Inc. (ISRG $586.24)
-
Eli Lilly and Company (LLY $1,063.56)
-
InMode Ltd. (INMD $14.44)
-
Lantheus Holdings Inc. (LNTH $67.56)
Q: Hi 5i team
I have investments in LLY and LNTH. Which among ISRG/INMD/ILMN has better potential for a 10+ year hold? and why?
Best,
Matt
I have investments in LLY and LNTH. Which among ISRG/INMD/ILMN has better potential for a 10+ year hold? and why?
Best,
Matt
Q: May I have your current thoughts on the iShares U.S. Medical Devices ETF (IHI). After a tough three months and today's 5% dip would you consider it an opportune time to add for medium to long term investors, or is it better to let it find its feet first?
Q: Hello 5i team,
I am thinking of adding to WELL. What is your current view of the company? Is it now profitable?
Thank You,
Andrew
I am thinking of adding to WELL. What is your current view of the company? Is it now profitable?
Thank You,
Andrew
Q: Good morning
Any reason you can see for a big up day yesterday and then a complete reversal down day today? Can't find any news for the up and down
Thks
Marcel
Any reason you can see for a big up day yesterday and then a complete reversal down day today? Can't find any news for the up and down
Thks
Marcel
Q: Hi Peter and Staff
Have held this for several years up a bit down a bit now it’s down more than a bit . Do you rate this sell , hold or buy
Further would you prefer a long term investment in DXCM or WELL
Thanks for all you do
Dennis
Have held this for several years up a bit down a bit now it’s down more than a bit . Do you rate this sell , hold or buy
Further would you prefer a long term investment in DXCM or WELL
Thanks for all you do
Dennis
-
Amgen Inc. (AMGN $326.10)
-
Intuitive Surgical Inc. (ISRG $586.24)
-
AbbVie Inc. (ABBV $220.08)
-
Johnson & Johnson (JNJ $204.39)
-
Eli Lilly and Company (LLY $1,063.56)
-
Medtronic plc. (MDT $97.53)
Q: Of the above health care stocks, could you rank from best to worst and indicate a good entry level for the top two. If you happen to have another better suggestion please rate accordingly.
Many thanks
Many thanks
Q: RDNT Is this company profitable? Do you see it as a buy, hold, or sell.
Q: This morning, Opsens received a takeover offer from Haemonetics. Do you think there's any potential for other bidders to offer more than the current $2.90 cash offer?
Many thanks.
Many thanks.
Q: With the NBLY share price below the "take private" offer, is there some reasonably low risk arbitrage here?
Q: Would you recommend LLY at the current somewhat elevated price?
With appreciation,
Ed
With appreciation,
Ed
Q: Do you think NBLY represents a reasonable arbitrage opportunity?
Thank-you!
Thank-you!
-
Intuitive Surgical Inc. (ISRG $586.24)
-
AbbVie Inc. (ABBV $220.08)
-
CVS Health Corporation (CVS $80.30)
-
Danaher Corporation (DHR $238.37)
-
Eli Lilly and Company (LLY $1,063.56)
-
Stryker Corporation (SYK $367.54)
-
Thermo Fisher Scientific Inc (TMO $618.86)
-
UnitedHealth Group Incorporated (DE) (UNH $343.98)
-
Novo Nordisk A/S (NVO $58.81)
Q: This period of seasonal weakness is a great time for some early Christmas shopping. I sold a part position in NVO a while ago and am looking to reinvest proceeds to increase my health care holdings.
Considering current valuations, what would you recommend as a good complement to expand and diversify?
Thanks in advance.
Considering current valuations, what would you recommend as a good complement to expand and diversify?
Thanks in advance.
Q: Hi 5i,
COR (formerly AmerisourceBergen) and MCK are classified as Healthcare Distributors. Do you like either of these in this area? Are both worth owning assuming you like them for a long term hold in a TFSA and NonReg account?
Can you please provide your high level thoughts for your choice.
COR (formerly AmerisourceBergen) and MCK are classified as Healthcare Distributors. Do you like either of these in this area? Are both worth owning assuming you like them for a long term hold in a TFSA and NonReg account?
Can you please provide your high level thoughts for your choice.
Q: WHICH CONSUMER STOCK MONDELEZ OR KENVUE WOULD BE BETTER NOW AND GOING FORWARD FOR THE FUTURE?
Q: You had a few comments about this this stock in the past month; one suggesting it being a buyable option below $152.
RBC Capital Markets has a $336 USD Target price and it sits on their Top 30 Global Ideas list. Morningstar rating is 5 with a Fair Value est. of $269. Currently seems to be a Hold among analysts. You have already some comments on recent corporate performance.
There is some noise of legal class action, yet not sure how significant this would be or whether it creates a drag on the stock. Add to the mix a new CEO.
I'd be very interested in your take on this stock given the above and its' meltdown with the market. Thanks, as always, for your insights.
RBC Capital Markets has a $336 USD Target price and it sits on their Top 30 Global Ideas list. Morningstar rating is 5 with a Fair Value est. of $269. Currently seems to be a Hold among analysts. You have already some comments on recent corporate performance.
There is some noise of legal class action, yet not sure how significant this would be or whether it creates a drag on the stock. Add to the mix a new CEO.
I'd be very interested in your take on this stock given the above and its' meltdown with the market. Thanks, as always, for your insights.
Q: What’s going on with Stryker, it’s on a significant downward trend?
Q: Can you give me an update on this stock and whether you would hold.It has come up nice lately
Q: Hi 5i,
I found the Q&A about Envista this morning very interesting. With the Veralto spinoff that is happening with DHR, do you think that Veralto will have the same low/no growth issues? I think DHR is trying to do the same again by keeping the higher growth assets and spinning off the lower growth ones. Would you hang on the the new shares when received or would you sell and maybe put back into DHR instead? TIA!
Wayne
I found the Q&A about Envista this morning very interesting. With the Veralto spinoff that is happening with DHR, do you think that Veralto will have the same low/no growth issues? I think DHR is trying to do the same again by keeping the higher growth assets and spinning off the lower growth ones. Would you hang on the the new shares when received or would you sell and maybe put back into DHR instead? TIA!
Wayne
Q: WELL Health seems to have a problem releasing their quarterly results in a timely fashion. Is there an acceptable reason for this or is this an indication poor management.